Stock Track | Savara Inc Soars 8.14% as Analysts Upgrade and Raise Price Targets

Stock Track

08/15

Savara Inc (SVRA) stock is surging 8.14% in pre-market trading on Friday, following a series of bullish analyst actions that have significantly boosted investor confidence. The biotechnology company has received multiple upgrades and price target increases, signaling growing optimism about its future prospects.

H.C. Wainwright made a notable move by upgrading Savara from Neutral to Buy and more than doubling its price target from $2 to $5. Analyst Andrew Fein cited improved resubmission prospects as a key factor in the upgrade. Simultaneously, Oppenheimer reiterated its Outperform rating on Savara and raised its price target from $5 to $6, further fueling the positive sentiment.

The overall analyst outlook for Savara remains bullish, with the company maintaining an average rating of Buy. According to analysts polled by FactSet, the mean price target for SVRA stock now stands at $7.93, suggesting significant upside potential from its current trading levels. This wave of positive analyst actions appears to be the primary driver behind Savara's pre-market rally, as investors react to the improved outlook for the company.

免責聲明：投資有風險，本文並非投資建議，以上內容不應被視為任何金融產品的購買或出售要約、建議或邀請，作者或其他用戶的任何相關討論、評論或帖子也不應被視為此類內容。本文僅供一般參考，不考慮您的個人投資目標、財務狀況或需求。TTM對信息的準確性和完整性不承擔任何責任或保證，投資者應自行研究並在投資前尋求專業建議。

熱議股票

1
2
3
4
5
6
7
8
9
10

{"basename":"/hant","ssrTDKData":{"titleTemplate":"%s - 老虎證券","title":"澳洲华人首选美澳港股一站式交易平台 | 老虎证券","description":"澳、美、港、A股、ETF、期权一站式在线交易，超低佣金，新手也能轻松开启投资。在老虎证券， 1 美元起投资美股，24/5 无时差交易美股，澳大利亚华人信赖的在线炒股平台。","keywords":"老虎证券,老虎证券澳洲,老虎证券股票,老虎证券开户,老虎证券app,tigertrade老虎证券,股票,asx美股,炒股,券商,澳洲股票交易,澳大利亚炒股","social":{"ogDescription":"澳、美、港、A股、ETF、期权一站式在线交易，超低佣金，新手也能轻松开启投资。在老虎证券， 1 美元起投资美股，24/5 无时差交易美股，澳大利亚华人信赖的在线炒股平台。","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.be62fbe1.png","ogUrl":"https://www.itiger.com/hant/news/1167300025"},"companyName":"老虎證券"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"AUS","license":"TBAU","edition":"fundamental"},"isCrawlerRequest":true,"__swrFallback__":{"@#url:\"https://stock-news.skytigris.cn/v3/news\",params:#id:\"1167300025\",edition:\"fundamental\",auth_exemption:1,,,undefined,":{"share":"https://ttm.financial/m/news/1167300025?lang=zh_TW&edition=fundamental","thumbnail":"","is_english":true,"pubTime":"2025-08-15 21:33","share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","id":"1167300025","market":"hk","top_or_hot":-1,"title":"Stock Track | Savara Inc Soars 8.14% as Analysts Upgrade and Raise Price Targets","media":"Stock Track","content":"<p>Savara Inc (SVRA) stock is surging 8.14% in pre-market trading on Friday, following a series of bullish analyst actions that have significantly boosted investor confidence. The biotechnology company has received multiple upgrades and price target increases, signaling growing optimism about its future prospects.</p>\n\n<p>H.C. Wainwright made a notable move by upgrading Savara from Neutral to Buy and more than doubling its price target from $2 to $5. Analyst Andrew Fein cited improved resubmission prospects as a key factor in the upgrade. Simultaneously, Oppenheimer reiterated its Outperform rating on Savara and raised its price target from $5 to $6, further fueling the positive sentiment.</p>\n\n<p>The overall analyst outlook for Savara remains bullish, with the company maintaining an average rating of Buy. According to analysts polled by FactSet, the mean price target for SVRA stock now stands at $7.93, suggesting significant upside potential from its current trading levels. This wave of positive analyst actions appears to be the primary driver behind Savara's pre-market rally, as investors react to the improved outlook for the company.</p>","source":"ai_movement_en","html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Stock Track | Savara Inc Soars 8.14% as Analysts Upgrade and Raise Price Targets</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 12.5px; color: #7E829C; margin: 0;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nStock Track | Savara Inc Soars 8.14% as Analysts Upgrade and Raise Price Targets\n</h2>\n<h4 class=\"meta\">\n<a class=\"head\" href=\"https://laohu8.com/wemedia/1086803395\">\n\n<div class=\"h-thumb\" style=\"background-image:url(https://static.tigerbbs.com/a81accab1e7ee4144dc051f71903a390);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">Stock Track </p>\n<p class=\"h-time smaller\">2025-08-15 21:33</p>\n</div>\n</a>\n</h4>\n</header>\n<article>\n<p>Savara Inc (SVRA) stock is surging 8.14% in pre-market trading on Friday, following a series of bullish analyst actions that have significantly boosted investor confidence. The biotechnology company has received multiple upgrades and price target increases, signaling growing optimism about its future prospects.</p>\n\n<p>H.C. Wainwright made a notable move by upgrading Savara from Neutral to Buy and more than doubling its price target from $2 to $5. Analyst Andrew Fein cited improved resubmission prospects as a key factor in the upgrade. Simultaneously, Oppenheimer reiterated its Outperform rating on Savara and raised its price target from $5 to $6, further fueling the positive sentiment.</p>\n\n<p>The overall analyst outlook for Savara remains bullish, with the company maintaining an average rating of Buy. According to analysts polled by FactSet, the mean price target for SVRA stock now stands at $7.93, suggesting significant upside potential from its current trading levels. This wave of positive analyst actions appears to be the primary driver behind Savara's pre-market rally, as investors react to the improved outlook for the company.</p>\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"SVRA","symbol_name":"Savara Inc","start_time":0,"source_url":"","article_id":"1167300025","we_media_id":"1086803395","thumbnails":[],"rights":null,"url":"https://stock-news.laohu8.com/highlight/detail?id=1167300025","pubTimestamp":1755264783,"columns":[],"sourceInfo":{"source_id":"ai_movement_en","name":"Stock Track"},"weMediaInfo":{"media_name":"Stock Track","introduction":"Track stock‘s movements and relevant news","home_visible":1,"id":"1086803395","head_image":"https://static.tigerbbs.com/a81accab1e7ee4144dc051f71903a390"},"summary":"Savara Inc (SVRA) stock is surging 8.14% in pre-market trading on Friday, following a series of bullish analyst actions that have significantly boosted investor confidence. The biotechnology company...","collect":0,"end_time":0,"defaultTopTitle":"","property":[],"viewcount":null,"language":"en","relate_stocks":{"SVRA":"Savara Inc"},"translate_title":"个股追踪|分析师上调目标价Savara Inc飙升8.14%","themeId":"","isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"SVRA":1},"content_text":"Savara Inc (SVRA) stock is surging 8.14% in pre-market trading on Friday, following a series of bullish analyst actions that have significantly boosted investor confidence. The biotechnology company has received multiple upgrades and price target increases, signaling growing optimism about its future prospects.\nH.C. Wainwright made a notable move by upgrading Savara from Neutral to Buy and more than doubling its price target from $2 to $5. Analyst Andrew Fein cited improved resubmission prospects as a key factor in the upgrade. Simultaneously, Oppenheimer reiterated its Outperform rating on Savara and raised its price target from $5 to $6, further fueling the positive sentiment.\nThe overall analyst outlook for Savara remains bullish, with the company maintaining an average rating of Buy. According to analysts polled by FactSet, the mean price target for SVRA stock now stands at $7.93, suggesting significant upside potential from its current trading levels. This wave of positive analyst actions appears to be the primary driver behind Savara's pre-market rally, as investors react to the improved outlook for the company.","kind":"news","is_publish_news":true,"is_publish_highlight":false,"is_publish_live":false,"is_publish_wemedia":null,"editions":null,"column":"","sentiment":"1","news_tag":"movement","news_rank":0,"symbols":[],"gpt_button":0,"need_auth":false,"code":"91000000","status":"200"}}}